We are live on ! Find out more
BA

BlackRock Advisors Portfolio holdings

AUM $98.8B
1-Year Est. Return 15.8%
This Fund
S&P 500
This Quarter Est. Return
+1.95%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.35%
5 Year Est. Return
10 Year Est. Return
AUM
$97.6B
AUM Growth
-$1.7B
Cap. Flow
-$3.16B
Cap. Flow %
-3.24%
Top 10 Hldgs %
14.39%
Holding
3,772
New
78
Increased
2,174
Reduced
812
Closed
154

Top Sells

Rank Stock Value
1
CVX icon
Chevron
CVX
+$382M
2
HSP
HOSPIRA INC
HSP
+$235M
3
MRK icon
Merck
MRK
+$227M
4
AGN
Allergan Inc
AGN
+$199M
5
AXP icon
American Express
AXP
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 19.47%
2 Financials 16.8%
3 Industrials 9.81%
4 Technology 8.84%
5 Energy 7.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNP
3351
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
$29K ﹤0.01%
4,676
CNXR
3352
DELISTED
Connecture, Inc.
CNXR
$29K ﹤0.01%
+2,784
New +$25.7K
FNCX
3353
DELISTED
Function(x) Inc.
FNCX
$29K ﹤0.01%
+1,012
New +$42.2K
MAG
3354
DELISTED
MAGNETEK INC COM STK NEW
MAG
$29K ﹤0.01%
750
PRMW
3355
DELISTED
Primo Water Corporation
PRMW
$29K ﹤0.01%
5,635
CVU icon
3356
CPI Aerostructures
CVU
$63.1M
$28K ﹤0.01%
2,281
FIVN icon
3357
FIVE9
FIVN
$1.96B
$28K ﹤0.01%
5,079
PEBK icon
3358
Peoples Bancorp of North Carolina
PEBK
$229M
$28K ﹤0.01%
1,647
PROV icon
3359
Provident Financial
PROV
$108M
$28K ﹤0.01%
1,737
RICK icon
3360
RCI Hospitality Holdings
RICK
$201M
$28K ﹤0.01%
2,654
RVSB icon
3361
Riverview Bancorp
RVSB
$108M
$28K ﹤0.01%
6,227
TVRD
3362
Tvardi Therapeutics
TVRD
$23.8M
$28K ﹤0.01%
78
+15
+24% +$5.68K
FRTX
3363
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$28K ﹤0.01%
9
BNK
3364
DELISTED
C1 FINL INC COM STK (FL)
BNK
$28K ﹤0.01%
1,508
+280
+23% +$4.91K
REN
3365
DELISTED
Resolute Energy Corporaton
REN
$28K ﹤0.01%
9,908
+2,061
+26% +$9.06K
NL icon
3366
NLI Holdings
NL
$283M
$27K ﹤0.01%
3,493
+737
+27% +$5.53K
VALU icon
3367
Value Line
VALU
$352M
$27K ﹤0.01%
1,830
CYBE
3368
DELISTED
Cyberoptics Corp
CYBE
$27K ﹤0.01%
2,661
WINT
3369
DELISTED
Windtree Therapeutics Inc
WINT
$27K ﹤0.01%
1,596
ADNC
3370
DELISTED
AUDIENCE INC COM STK (DE)
ADNC
$27K ﹤0.01%
5,958
BRT
3371
BRT Apartments
BRT
$283M
$26K ﹤0.01%
3,601
CRDF icon
3372
Cardiff Oncology
CRDF
$65M
$26K ﹤0.01%
52
FBIO icon
3373
Fortress Biotech
FBIO
$109M
$26K ﹤0.01%
454
IRD
3374
Opus Genetics
IRD
$277M
$26K ﹤0.01%
75
BSF
3375
DELISTED
Bear State Financial, Inc.
BSF
$26K ﹤0.01%
2,595

Similar funds

BlackRock Advisors's Q1 2015 Portfolio in Review

As of Q1 2015, BlackRock Advisors held 3,772 positions worth $97.6B, down 1.7% from $99.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

BlackRock Advisors withdrew a net $3.16B in Q1 2015, closing 154 positions and reducing 812 holdings. Its most notable exit was Allergan Inc, an estimated $199M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Financials and Industrials.

Against the trend, BlackRock Advisors opened a new position in Mobileye N.V. worth $252M.

  • BlackRock Advisors's largest Q1 2015 buy was Mobileye N.V.: 6,000,666 shares worth $252M.
  • BlackRock Advisors added most to UnitedHealth in Q1 2015, an estimated $461M increase.
  • BlackRock Advisors's biggest Q1 2015 reduction was Chevron, cutting an estimated $382M.
  • BlackRock Advisors fully exited Allergan Inc in Q1 2015, selling an estimated $199M.
  • BlackRock Advisors's ten largest holdings make up 14% of its $97.6B portfolio in Q1 2015.
  • BlackRock Advisors opened 78 new positions and closed 154 in Q1 2015.
  • BlackRock Advisors's portfolio value fell 1.7% quarter-over-quarter to $97.6B.

Based on BlackRock Advisors's 13F filing for Q1 2015, filed 13 May 2015.